Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cancer Drug Taxol Promotes Nerve Growth within Central Nervous System

17.02.2011
Using the optic nerve model, medical scientists from Düsseldorf / Ulm, Germany, headed by Prof. Dr. Dietmar Fischer, have demonstrated that paclitaxel, an approved cancer drug known as Taxol for two decades, facilitates the regeneration of nerve fibers, called axons, in the brain and central nervous system.

Once severed by injury, axons in the spinal cord or optic nerve cannot regenerate and remain disconnected from their original target areas. As a result, affected patients suffer permanent functional impairment or disability such as paraplegia or blindness.

“Using a low dose of Taxol locally at the site of injury is crucial to leveraging the regeneration-promoting effects of Taxol”, says Dietmar Fischer, Professor of Experimental Neurology, Department of Neurology, Heinrich-Heine-Universität Düsseldorf, Germany.

These research results have most recently been published in the Journal of Neuroscience (February, 16, 2011 issue). Similar findings were obtained in the spinal cord of rats studied by an international research team led by the Max-Planck-Institut für Neurobiologie, Martinsried, Germany, and published a few days ago in the journal Science. These results demonstrate that Taxol can be used in various parts of the brain and spinal cord to successfully facilitate nerve fiber regeneration.

Used in the right dose, the drug simultaneously targets several mechanisms that normally prevent nerve growth: Taxol stabilizes specific structures (microtubules) in the growth cones of injured nerve fibers, resulting in substantially enhanced elongation. In addition, Taxol abolishes growth cone sensitivity to growth-blocking molecules which are normally in their vicinity after injury. Moreover, local administration of this cancer drug delays scar formation at the site of injury and suppresses the synthesis of growth-inhibiting molecules, thus substantially reducing this barrier to regeneration.

These current findings, generated independently and simultaneously by two teams of reseachers in different models – the spinal cord in one study and the rat optic nerve in the present study – are encouraging indeed, holding out the promise of continued therapeutic development as these results have been obtained for a clinically established human drug. “We are cautious about predicting the potential of Taxol or similar drugs for use in humans”, Prof. Fischer emphasizes, “although Taxol or similar drugs might be promising candidates for the treatment of injuries to the central nervous system, be it from stroke or trauma. While more studies are clearly needed, from the scientific standpoint we now have an additional strategy for the development of new treatments for repairing central nervous system injuries.”

Contact: Prof. Dr. Dietmar Fischer, Experimentelle Neurologie, Klinik für Neurologie, Universitätsklinikum Düsseldorf, Phone: +49 015253838060, Mobile: +49 (0)173 3299792, E-mail: dietmar.fischer@uni-duesseldorf.de; www.fischerlab.de

Susanne Dopheide | idw
Further information:
http://www.uniklinik-duesseldorf.de/neurologie

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>